HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Treatment of shunt-related cerebral ventriculitis due to Corynebacterium jeikeium with vancomycin administered intraventricularly. Case report.

Abstract
A 52-year-old female with subarachnoid haemorrhage and hydrocephalus was treated with external and later internal drainage. She developed ventriculoperitoneal shunt-related ventriculitis caused by Corynebacterium jeikeium. The infection was unsuccessfully treated with intravenous vancomycin. It was controlled only after shunt removal and administration of intraventricular vancomycin as well as systemic vancomycin, rifampicin and fusidic acid. A review of the literature confirmed our experience that vancomycin given intraventricularly is well tolerated and doses can be individualized by measuring vancomycin levels in cerebrospinal fluid.
AuthorsJ D Knudsen, C J Nielsen, F Espersen
JournalAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica (APMIS) Vol. 102 Issue 4 Pg. 317-20 (Apr 1994) ISSN: 0903-4641 [Print] DENMARK
PMID8011309 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Vancomycin
Topics
  • Catheterization (adverse effects)
  • Cerebral Ventricles
  • Cerebrospinal Fluid Shunts (adverse effects)
  • Corynebacterium (pathogenicity)
  • Corynebacterium Infections (drug therapy)
  • Encephalitis (drug therapy)
  • Female
  • Humans
  • Middle Aged
  • Vancomycin (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: